Middle East and Africa ePRO, ePatient Diaries, and eCOA Market

Market Introduction

The usage of electronic Clinical Outcome Assessment (eCOA) is a push towards adapting to the ‘new normal’ as it is a method to gather patient data electronically through the use of technology such as smart home devices, handheld monitors, wearables, e-diaries, tablets and web servers to allow the stakeholders in the trials (patients, healthy volunteers, investigators and caregivers) to report outcomes directly and digitally. Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO and ObsRO along with PRO. In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum.

eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and speeds trials. Such a system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized, accurate studies. The increasing adoption of EHR, and government regulations mandating maintain health records is driving the growth of the market.

Thus, a growing demand for clinical trials is expected to create a significant demand for ePRO, ePatient Diaries, and eCOA in the coming years, which is further anticipated to drive the ePRO, ePatient Diaries, and eCOA market.

The COVID-19 pandemic has accelerated much-needed changes in clinical trial conduct, including an increase in the use of ePRO and other remote-assessment technologies. Sponsors and CROs have been using technology for various research activities, from patient consent and consultation to PROs and side monitoring, driven by the need to implement new methods for working and communicating with study participants.

Market Overview and Dynamics

The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. With an increase in clinical trials and the need to be able to easily centralize data capture, as well as the need to drive down the overall cost of bringing a new drug to market, the adoption of ePRO, e-Patient Diaries, and eCOA platforms will be on rise as capturing data using eCOA solutions not only improves the quality of data, but also complements the data collection process across the study, leading to reduced risk and providing significant value. Additionally, majority of clinical trial stakeholders including sponsors, CROs and regulators consider eCOA as the most effective way to capture high-quality and more reliable data than traditional, paper-based methods.

Key Market Segments

In terms of type of solution, the e-clinical outcome assessments segment accounted for the largest share of the Middle East and Africa ePRO, ePatient Diaries, and eCOA market in 2020. In terms of modality, the mobile devices segment held a larger market share of the ePRO, ePatient Diaries, and eCOA market in 2020. In terms of end user, the cinical trial sponsors segment held a larger market share of the ePRO, ePatient Diaries, and eCOA market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the EPRO, ePatient Diaries, and eCOA market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Bracket Global LLC, Dassault Systèmes SE, and CRF Health.

Reasons to buy report

• To understand the Middle East and Africa ePRO, ePatient Diaries, and eCOA market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa ePRO, ePatient Diaries, and eCOA market
• Efficiently plan M&A and partnership deals in Middle East and Africa ePRO, ePatient Diaries, and eCOA market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa ePRO, ePatient Diaries, and eCOA market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East and Africa region.

MIDDLE EAST AND AFRICA EPRO, EPATIENT DIARIES, AND ECOA MARKET SEGMENTATION

By Type of Solution

• eClinical Outcome Assessments
• e-Patient Reported Outcomes
• Clinician Reported Outcomes
• Observer Reported Outcomes
• Performance Outcomes
• e-Patient Diaries

By Modality

• Computer
• Mobile Devices

By End User

• Clinical Trial Sponsors
• Contract Research Organizations
• Hospitals
• Academic Institutes
• Pharmaceutical Companies
• Others

By Country

• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned

1. The Diary Pte. Ltd                
2. ICON PLC                
3. PAREXEL INTERNATIONAL CORPORATION   
4. Bracket Global LLC              
5. Dassault Systèmes SE        
6. CRF Health             

Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Strategic Insights

Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Segmentation Analysis

Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Report Highlights

Middle East and Africa ePRO, ePatient Diaries, and eCOA Report Scope

Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Country and Regional Insights